1. Zhong S., Zhao L., Wang Y., Zhang C., Liu J., Wang P., Zhou W., Yang P., Varghese Z., Moorhead J. F., Chen Y., Ruan X. Z. (2017) Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway. Antioxid Redox Signal 27: 201-214.（IF: 6.337）
2. Zhang Q. F., Yin W. W., Xia Y., Yi Y. Y., He Q. F., Wang X., Ren H., Zhang D. Z. (2017) Liver-infiltrating CD11b(-)CD27(-) NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression. Cell Mol Immunol 14: 819-829.（IF: 5.897）
3. Li S., Yang Y., Ding X., Yang M., She S., Peng H., Xu X., Ran X., Li S., Hu P., Hu H., Zhang D., Ren H. (2017) LHBs can elevate the expression of MDR1 through HIF-1alpha in patients with CHB infection: a comparative proteomic study. Oncotarget 8: 4549-4562.（IF: 5.168）
4. Tuo H., Shu F., She S., Yang M., Zou X. Q., Huang J., Hu H. D., Hu P., Ren H., Peng S. F.（*）, Yang Y. X. (2017) Sorcin induces gastric cancer cell migration and invasion contributing to STAT3 activation. Oncotarget 8: 104258-104271.（IF: 5.168）
5. Zhu L., Yang N., Chen J., Zeng T., Yan S., Liu Y., Yu G., Chen Q., Du G., Pan W., Li X., Zhou H., Huang A., Tang H.(2017) LINC00052 upregulates EPB41L3 to inhibit migration and invasion of hepatocellular carcinoma by binding miR-452-5p. Oncotarget 8: 63724-63737.（IF: 5.168）
6. Fan J., Wei Q., Liao J., Zou Y., Song D., Xiong D., Ma C., Hu X., Qu X., Chen L., Li L., Yu Y., Yu X., Zhang Z., Zhao C., Zeng Z., Zhang R., Yan S., Wu T., Wu X., Shu Y., Lei J., Li Y., Zhang W., Haydon R. C., Luu H. H., Huang A., He T. C., Tang H. (2017) Noncanonical Wnt signaling plays an important role in modulating canonical Wnt-regulated stemness, proliferation and terminal differentiation of hepatic progenitors. Oncotarget 8: 27105-27119.（IF: 5.168）
7. Yang P., Xiao Y., Luo X., Zhao Y., Zhao L., Wang Y., Wu T., Wei L., Chen Y. (2017) Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice. J Lipid Res 58: 1417-1427.（IF: 4.81）
8. Chen Y., Hu J., Cai X., Huang Y., Zhou X., Tu Z., Hu J., Tavis J. E., Tang N., Huang A., Hu Y. (2018) APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription. Antiviral Res 149: 16-25.（IF: 4.271）
9. Tong S., Liu G., Li M., Li X., Liu Q., Peng H., Li S., Ren H., Yin W. (2017) Natural killer cell activation contributes to hepatitis B viral control in a mouse model. Sci Rep 7: 314.（IF:4.259）
10. Mu D., Yuan F. C., Chen Y., Jiang X. Y., Yan L., Jiang L. Y., Gong J. P., Zhang D. Z., Ren H., Liao Y. (2017) Baseline value of intrahepatic HBV DNA over cccDNA predicts patient's response to interferon therapy. Sci Rep 7: 5937.（IF: 4.259）
11. Song L., Huang W., Kang J., Huang Y., Ren H., Ding K. (2017) Comparison of error correction algorithms for Ion Torrent PGM data: application to hepatitis B virus. Sci Rep 7: 8106.（IF: 4.259）
12. Li S. Y., Li H., Xiong Y. L., Liu F., Peng M. L., Zhang D. Z., Ren H., Hu P. (2017) Peginterferon is preferable to entecavir for prevention of unfavourable events in patients with HBeAg-positive chronic hepatitis B: A five-year observational cohort study. J Viral Hepat 24 Suppl 1: 12-20.（IF: 4.122）
13. Ren H. (2017) The experience of management of chronic hepatitis B in China. J Viral Hepat 24 Suppl 1: 4-5.（IF: 4.122）
14. Gao Q., Wang K., Chen K., Liang L., Zheng Y., Zhang Y., Xiang J., Tang N. (2017) HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma. Cancer Sci 108: 1328-1337. （IF: 3.974）
15. Chen Z. W., Pang X. C., Li Z., Ren H., Hu P. (2017) Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients. Infect Drug Resist 10: 275-281.（IF: 3.779）
16. Li Z., Chen Z. W., Li H., Ren H., Hu P. (2017) Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naive hepatitis C genotype 1b-infected patients in western China. Infect Drug Resist 10: 377-392.（IF: 3.779）
17. Xu Y., Shi Y., Zhou J., Yang W., Bai L., Wang S., Jin X., Niu Q., Huang A., Wang D. (2017) Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase. Microb Cell Fact 16: 197.（IF: 3.681）
18. Huang J., Zhao L., Yang P., Chen Z., Ruan X. Z., Huang A., Tang N., Chen Y. (2017) Fatty acid translocase promoted hepatitis B virus replication by upregulating the levels of hepatic cytosolic calcium. Exp Cell Res 358: 360-368.（IF: 3.546）
19. Wu C. X., Cheng J., Wang Y. Y., Wang J. J., Guo H., Sun H. (2017) Microrna Expression Profiling of Macrophage Line Raw264.7 Infected by Candida Albicans. Shock 47: 520-530.（IF: 3.113）
20. Gong J., Shen S., Yang Y., Qin S., Huang L., Zhang H., Chen L., Chen Y., Li S., She S., Yang M., Ren H., Hu H. (2017) Inhibition of FASN suppresses migration, invasion and growth in hepatoma carcinoma cells by deregulating the HIF-1alpha/IGFBP1 pathway. Int J Oncol 50: 883-892.（IF: 3.079）
21. Yang M., Wang C., Li S., Xv X., She S., Ran X., Li S., Hu H., Hu P., Zhang D., Zheng Y., Yang Y., Ren H. (2017) Annexin A2 promotes liver fibrosis by mediating von Willebrand factor secretion. Dig Liver Dis 49: 780-788.（IF: 3.061）
22. Liu B., Gao W., Zhang L., Wang J., Chen M., Peng M., Ren H., Hu P. (2017) Th17/Treg imbalance and increased interleukin-21 are associated with liver injury in patients with chronic severe hepatitis B. Int Immunopharmacol 46: 48-55.（IF: 2.956）
23. Li S., Liu B., Peng M., Chen M., Yin W., Tang H., Luo Y., Hu P., Ren H.（任红） (2017) Diagnostic accuracy of Xpert MTB/RIF for tuberculosis detection in different regions with different endemic burden: A systematic review and meta-analysis. PLoS One 12: e0180725.（IF: 2.806）
24. Luo M., Zhang X., Zhang S., Zhang H., Yang W., Zhu Z., Chen K., Bai L., Wei J., Huang A., Wang D. (2017) Crystal Structure of an Invasivity-Associated Domain of SdrE in S. aureus. PLoS One 12: e0168814.（IF: 2.806）
25. Zeng T., Wang D., Chen J., Tian Y., Cai X., Peng H., Zhu L., Huang A. Tang H. (2017) LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells. PLoS One 12: e0177843.（IF: 2.806）
26. Cheng S. T., Tang H., Ren J. H., Chen X., Huang A. L., Chen J. (2017) Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo. PLoS One 12: e0179605.（IF: 2.806）
27. Liu Y., Cheng F., Luo Y., Zhan Z., Hu P., Ren H., Tang H., Peng M. (2017) PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-gamma/CD36 Pathway. Biomed Res Int 2017: 8234507.（IF: 2.476）
28. Feng L., Gu C., Li Y., Huang J. (2017) High Glucose Promotes CD36 Expression by Upregulating Peroxisome Proliferator-Activated Receptor gamma Levels to Exacerbate Lipid Deposition in Renal Tubular Cells. Biomed Res Int 2017: 1414070.（IF: 2.476）
29. Tao N. N., Ren J. H., Tang H., Ran L. K., Zhou H. Z., Liu B., Huang A. L., Chen J. (2017) Deacetylation of Ku70 by SIRT6 attenuates Bax-mediated apoptosis in hepatocellular carcinoma. Biochem Biophys Res Commun 485: 713-719.（IF: 2.466）
30. Gao H., Li D., Yang P., Zhao L., Wei L., Chen Y., Ruan X. Z. (2017) Suppression of CD36 attenuates adipogenesis with a reduction of P2X7 expression in 3T3-L1 cells. Biochem Biophys Res Commun 491: 204-208.（IF: 2.466）
31. Tang H., Zhang Z., Li Z., Lin J., Fang D. Z. (2017) High-Carbohydrate/Low-Fat Diet-Induced Gender-Specific Serum Lipid Profile Changes Are Associated with LEPR Polymorphisms in Chinese Youth. Ann Nutr Metab 70: 1-8.（IF: 2.424）
32. Meng T., Shi X., Gong X., Deng H., Huang Y., Shan X., Shan Y., Huang A., Long Q. (2017) Analysis of the prevalence of drug-resistant hepatitis B virus in patients with antiviral therapy failure in a Chinese tertiary referral liver centre (2010-2014). J Glob Antimicrob Resist 8: 74-81.（IF: 1.276）
33. Peng H., Li Y., Liu Y., Zhang J., Chen K., Huang A., Tang H. (2017) HBx and SP1 upregulate DKK1 expression. Acta Biochim Pol 64: 35-39.（IF: 1.159）
34. Shen S. S., Gong J. J., Wang X. W., Chen L., Qin S., Huang L. F., Chen Y. Q., Ren H., Yang Q. B., Hu H. D. (2017) Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis. Turk J Gastroenterol 28: 31-39.（IF: 0.932）
35. Cheng F., Chen Y., Zhan Z., Liu Y., Hu P., Ren H., Tang H., Peng M. (2017) Curc-mPEG454, a PEGylated Curcumin Derivative, Improves Anti-inflammatory and Antioxidant Activities: a Comparative Study. Inflammation.（IF:2.618）
36. Zeng T., Wang D., Chen J., Chen K., Yu G., Chen Q., Liu Y., Yan S., Zhu L., Zhou H., Huang A., Tang H. (2017) AF119895 regulates NXF3 expression to promote migration and invasion of hepatocellular carcinoma through an interaction with miR-6508-3p. Exp Cell Res.（IF:3.378）
37. Shen S., Gong J., Yang Y., Qin S., Huang L., She S., Yang M., Ren H., Hu H. (2017) Molecular mechanism of C-reaction protein in promoting migration and invasion of hepatocellular carcinoma cells in vitro. Int J Oncol.（IF:3.018）